The immunogenicity of human embryonic stem-derived cells

Trends in Biotechnology

Volumn 22, Issue 3, 2004, Pages 136-141

  Drukker, Micha ^a   Benvenisty, Nissim ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CELLS; IMMUNOLOGY; TISSUE;

CELL TRANSPLANTATION; EMBRYONIC STEM CELLS;

BIOTECHNOLOGY;

ALLOANTIBODY; ALLOANTIGEN; ALPHA INTERFERON; BETA INTERFERON; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA G ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOCHONDRIAL DNA; TRANSFORMING GROWTH FACTOR BETA;

EMBRYO;

ANTIBODY PRODUCTION; ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; APOPTOSIS; BLASTOCYST; BONE MARROW CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL KILLING; CELL MIGRATION; CELL NUCLEUS TRANSPLANTATION; CELL PROLIFERATION; CELL STIMULATION; CHIMERA; COMPLEMENT SYSTEM; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DNA MICROARRAY; EMBRYO; GENE LOCUS; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HELPER CELL; HEMATOPOIETIC CELL; HLA MATCHING; HLA SYSTEM; HOMOZYGOSITY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MOLECULAR MECHANICS; NATURAL KILLER CELL; NONHUMAN; OOCYTE; PARTHENOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE; UPREGULATION;

EID: 1242338093     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2004.01.003     Document Type: Review

References (66)

1. Thomson J.A., et al. Embryonic stem cell lines derived from human blastocysts. Science. 282:1998;1145-1147.
2. Reubinoff B.E., et al. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18:2000;399-404.
3. Itskovitz-Eldor J., et al. Differentiation of human embryonic stem cells into embryoid bodies comprising the three embryonic germ layers. Mol. Med. 6:2000;88-95.
4. Schuldiner M., et al. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 97:2000;11307-11312.
5. Schuldiner M., et al. Induced neuronal differentiation of human embryonic stem cells. Brain Res. 913:2001;201-205.
6. Zhang S.C., et al. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat. Biotechnol. 19:2001;1129-1133.
7. Reubinoff B.E., et al. Neural progenitors from human embryonic stem cells. Nat. Biotechnol. 19:2001;1134-1140.
8. Carpenter M.K., et al. Enrichment of neurons and neural precursors from human embryonic stem cells. Exp. Neurol. 172:2001;383-397.
9. Xu R.H., et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat. Biotechnol. 20:2002;1261-1264.
10. Levenberg S., et al. Endothelial cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 99:2002;4391-4396.
11. Kehat I., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108:2001;407-414.
12. Xu C., et al. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ. Res. 91:2002;501-508.
13. Mummery C., et al. Cardiomyocyte differentiation of mouse and human embryonic stem cells. J. Anat. 200:2002;233-242.
14. Kehat I., et al. High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel in vitro model for the study of conduction. Circ. Res. 91:2002;659-661.
15. He J.Q., et al. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ. Res. 93:2003;32-39.
16. Mummery C., et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation. 107:2003;2733-2740.
17. Kaufman D.S., et al. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 98:2001;10716-10721.
18. Chadwick K., et al. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood. 102:2003;906-915.
19. Rambhatla L., et al. Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant. 12:2003;1-11.
20. Capecchi M.R. Generating mice with targeted mutations. Nat. Med. 7:2001;1086-1090.
21. Eiges R., et al. Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr. Biol. 11:2001;514-518.
22. Zwaka T.P., Thomson J.A. Homologous recombination in human embryonic stem cells. Nat. Biotechnol. 21:2003;319-321.
23. Pfeifer A., et al. Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc. Natl. Acad. Sci. U. S. A. 99:2002;2140-2145.
24. Ma Y., et al. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells. 21:2003;111-117.
25. Roopenian D., et al. The immunogenomics of minor histocompatibility antigens. Immunol. Rev. 190:2002;86-94.
26. Watkins W.M. The ABO blood group system: historical background. Transfus. Med. 11:2001;243-265.
27. Schreuder G.M., et al. The HLA Dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Eur. J. Immunogenet. 28:2001;565-596.
28. Fleischhauer K., et al. Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N. Engl. J. Med. 323:1990;1818-1822.
29. Drukker M., et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 99:2002;9864-9869.
30. Tian L., et al. Expression of immunoglobulin superfamily cell adhesion molecules on murine embryonic stem cells. Biol. Reprod. 57:1997;561-568.
31. Draper J.S., et al. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J. Anat. 200:2002;249-258.
32. Andrews P.W., et al. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection. Cancer Res. 47:1987;740-746.
33. Zavazava N., Kabelitz D. Alloreactivity and apoptosis in graft rejection and transplantation tolerance. J. Leukoc. Biol. 68:2000;167-174.
34. Gould D.S., Auchincloss H. Jr. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol. Today. 20:1999;77-82.
35. Rogers N.J., Lechler R.I. Allorecognition. Am. J. Transplant. 1:2001;97-102.
36. Iwai H., et al. Acceptance of murine thyroid allografts by pretreatment of anti-Ia antibody or anti-dendritic cell antibody in vitro. Transplantation. 47:1989;45-49.
37. Kaech S.M., Ahmed R. CD8 T cells remember with a little help. Science. 300:2003;263-265.
38. Boisgerault F., et al. Induction of T-cell response to cryptic MHC determinants during allograft rejection. Hum. Immunol. 61:2000;1352-1362.
39. Sirak J., et al. Alloreactive delayed-type hypersensitivity in graft recipients: complexity of responses and divergence from acute rejection. Transplantation. 63:1997;1300-1307.
40. Wood K.J., Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3:2003;199-210.
41. Kovats S., et al. A class I antigen, HLA-G, expressed in human trophoblasts. Science. 248:1990;220-223.
42. Ferguson T.A., et al. Cell death and immune privilege. Int. Rev. Immunol. 21:2002;153-172.
43. Green D.R., Ferguson T.A. The role of Fas ligand in immune privilege. Nat. Rev. Mol. Cell Biol. 2:2001;917-924.
44. Freed C.R., et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344:2001;710-719.
45. Rubinstein P. HLA matching for bone marrow transplantation - how much is enough? N. Engl. J. Med. 345:2001;1842-1844.
46. Petersdorf E.W., et al. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N. Engl. J. Med. 345:2001;1794-1800.
47. Kawase E., et al. Mouse embryonic stem (ES) cell lines established from neuronal cell-derived cloned blastocysts. Genesis. 28:2000;156-163.
48. Munsie M.J., et al. Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei. Curr. Biol. 10:2000;989-992.
49. Wakayama T., et al. Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science. 292:2001;740-743.
50. Cibelli J.B., et al. Transgenic bovine chimeric offspring produced from somatic cell-derived stem-like cells. Nat. Biotechnol. 16:1998;642-646.
51. Cibelli J.B., et al. Somatic cell nuclear transfer in humans: pronuclear and early embryonic development. E-biomed. Regenerative Med. 2:2001;25-31.
52. Tada M., et al. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 11:2001;1553-1558.
53. Serov O., et al. Embryonic hybrid cells: a powerful tool for studying pluripotency and reprogramming of the differentiated cell chromosomes. An. Acad. Bras. Cienc. 73:2001;561-568.
54. Lanza R.P., et al. Generation of histocompatible tissues using nuclear transplantation. Nat. Biotechnol. 20:2002;689-696.
55. Cibelli J.B., et al. Parthenogenetic stem cells in nonhuman primates. Science. 295:2002;819.
56. Hochedlinger K., Jaenisch R. Nuclear transplantation, embryonic stem cells, and the potential for cell therapy. N. Engl. J. Med. 349:2003;275-286.
57. Simerly C., et al. Molecular correlates of primate nuclear transfer failures. Science. 300:2003;297.
58. Sykes M. Mixed chimerism and transplant tolerance. Immunity. 14:2001;417-424.
59. van den Brink M.R., Burakoff S.J. Cytolytic pathways in haematopoietic stem-cell transplantation. Nat. Rev. Immunol. 2:2002;273-281.
60. Fandrich F., et al. Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat. Med. 8:2002;171-178.
61. Waldmann H. Transplantation tolerance - where do we stand? Nat. Med. 5:1999;1245-1248.
62. Zijlstra M., et al. Beta 2-microglobulin deficient mice lack CD4-8+cytolytic T cells. Nature. 344:1990;742-746.
63. Grusby M.J., et al. Mice lacking major histocompatibility complex class I and class II molecules. Proc. Natl. Acad. Sci. U. S. A. 90:1993;3913-3917.
64. Dierich A., et al. Graft rejection by T cells not restricted by conventional major histocompatibility complex molecules. Eur. J. Immunol. 23:1993;2725-2728.
65. Bix M., et al. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature. 349:1991;329-331.
66. Griffith T.S., et al. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1995;1189-1192.